141 related articles for article (PubMed ID: 38835911)
1. Factors influencing reduced penetrance and variable expressivity in X-linked dystonia-parkinsonism.
Pozojevic J; von Holt BH; Westenberger A
Med Genet; 2022 Jun; 34(2):97-102. PubMed ID: 38835911
[TBL] [Abstract][Full Text] [Related]
2. X-linked dystonia-parkinsonism: over and above a repeat disorder.
Pozojevic J; Cruz JN; Westenberger A
Med Genet; 2021 Dec; 33(4):319-324. PubMed ID: 38835428
[TBL] [Abstract][Full Text] [Related]
3. A hexanucleotide repeat modifies expressivity of X-linked dystonia parkinsonism.
Westenberger A; Reyes CJ; Saranza G; Dobricic V; Hanssen H; Domingo A; Laabs BH; Schaake S; Pozojevic J; Rakovic A; Grütz K; Begemann K; Walter U; Dressler D; Bauer P; Rolfs A; Münchau A; Kaiser FJ; Ozelius LJ; Jamora RD; Rosales RL; Diesta CCE; Lohmann K; König IR; Brüggemann N; Klein C
Ann Neurol; 2019 Jun; 85(6):812-822. PubMed ID: 30973967
[TBL] [Abstract][Full Text] [Related]
4. Mosaic divergent repeat interruptions in XDP influence repeat stability and disease onset.
Trinh J; Lüth T; Schaake S; Laabs BH; Schlüter K; Laβ J; Pozojevic J; Tse R; König I; Jamora RD; Rosales RL; Brüggemann N; Saranza G; Diesta CCE; Kaiser FJ; Depienne C; Pearson CE; Westenberger A; Klein C
Brain; 2023 Mar; 146(3):1075-1082. PubMed ID: 35481544
[TBL] [Abstract][Full Text] [Related]
5. Identifying genetic modifiers of age-associated penetrance in X-linked dystonia-parkinsonism.
Laabs BH; Klein C; Pozojevic J; Domingo A; Brüggemann N; Grütz K; Rosales RL; Jamora RD; Saranza G; Diesta CCE; Wittig M; Schaake S; Dulovic-Mahlow M; Quismundo J; Otto P; Acuna P; Go C; Sharma N; Multhaupt-Buell T; Müller U; Hanssen H; Kilpert F; Franke A; Rolfs A; Bauer P; Dobričić V; Lohmann K; Ozelius LJ; Kaiser FJ; König IR; Westenberger A
Nat Commun; 2021 May; 12(1):3216. PubMed ID: 34050153
[TBL] [Abstract][Full Text] [Related]
6. Elucidating Hexanucleotide Repeat Number and Methylation within the X-Linked Dystonia-Parkinsonism (XDP)-Related SVA Retrotransposon in
Lüth T; Laβ J; Schaake S; Wohlers I; Pozojevic J; Jamora RDG; Rosales RL; Brüggemann N; Saranza G; Diesta CCE; Schlüter K; Tse R; Reyes CJ; Brand M; Busch H; Klein C; Westenberger A; Trinh J
Genes (Basel); 2022 Jan; 13(1):. PubMed ID: 35052466
[TBL] [Abstract][Full Text] [Related]
7. Variation in TAF1 expression in female carrier induced pluripotent stem cells and human brain ontogeny has implications for adult neostriatum vulnerability in X-linked Dystonia Parkinsonism.
D'Ignazio L; Jacomini RS; Qamar B; Benjamin KJM; Arora R; Sawada T; Evans TA; Diffenderfer KE; Pankonin AR; Hendriks WT; Hyde TM; Kleinman JE; Weinberger DR; Bragg DC; Paquola ACM; Erwin JA
eNeuro; 2022 Jul; 9(4):. PubMed ID: 35868859
[TBL] [Abstract][Full Text] [Related]
8. Disease onset in X-linked dystonia-parkinsonism correlates with expansion of a hexameric repeat within an SVA retrotransposon in
Bragg DC; Mangkalaphiban K; Vaine CA; Kulkarni NJ; Shin D; Yadav R; Dhakal J; Ton ML; Cheng A; Russo CT; Ang M; Acuña P; Go C; Franceour TN; Multhaupt-Buell T; Ito N; Müller U; Hendriks WT; Breakefield XO; Sharma N; Ozelius LJ
Proc Natl Acad Sci U S A; 2017 Dec; 114(51):E11020-E11028. PubMed ID: 29229810
[TBL] [Abstract][Full Text] [Related]
9. X-linked dystonia parkinsonism: epidemiology, genetics, clinical features, diagnosis, and treatment.
Chin HL; Lin CY; Chou OH
Acta Neurol Belg; 2023 Feb; 123(1):45-55. PubMed ID: 36418540
[TBL] [Abstract][Full Text] [Related]
10. Tissue-specific and repeat length-dependent somatic instability of the X-linked dystonia parkinsonism-associated CCCTCT repeat.
Campion LN; Mejia Maza A; Yadav R; Penney EB; Murcar MG; Correia K; Gillis T; Fernandez-Cerado C; Velasco-Andrada MS; Legarda GP; Ganza-Bautista NG; Lagarde JBB; Acuña PJ; Multhaupt-Buell T; Aldykiewicz G; Supnet ML; De Guzman JK; Go C; Sharma N; Munoz EL; Ang MC; Diesta CCE; Bragg DC; Ozelius LJ; Wheeler VC
Acta Neuropathol Commun; 2022 Apr; 10(1):49. PubMed ID: 35395816
[TBL] [Abstract][Full Text] [Related]
11. Decreased N-TAF1 expression in X-linked dystonia-parkinsonism patient-specific neural stem cells.
Ito N; Hendriks WT; Dhakal J; Vaine CA; Liu C; Shin D; Shin K; Wakabayashi-Ito N; Dy M; Multhaupt-Buell T; Sharma N; Breakefield XO; Bragg DC
Dis Model Mech; 2016 Apr; 9(4):451-62. PubMed ID: 26769797
[TBL] [Abstract][Full Text] [Related]
12. The Effect of Glucocorticoids on
Cruz SED; Bagamasbad P
J ASEAN Fed Endocr Soc; 2023; 38(1):23-30. PubMed ID: 37234925
[TBL] [Abstract][Full Text] [Related]
13. Dissection of
Capponi S; Stöffler N; Penney EB; Grütz K; Nizamuddin S; Vermunt MW; Castelijns B; Fernandez-Cerado C; Legarda GP; Velasco-Andrada MS; Muñoz EL; Ang MA; Diesta CCE; Creyghton MP; Klein C; Bragg DC; De Rijk P; Timmers HTM
Brain Commun; 2021; 3(4):fcab253. PubMed ID: 34746789
[TBL] [Abstract][Full Text] [Related]
14. Proteomic analysis of X-linked dystonia parkinsonism disease striatal neurons reveals altered RNA metabolism and splicing.
Tshilenge KT; Bons J; Aguirre CG; Geronimo-Olvera C; Shah S; Rose J; Gerencser AA; Mak SK; Ehrlich ME; Bragg DC; Schilling B; Ellerby LM
Neurobiol Dis; 2024 Jan; 190():106367. PubMed ID: 38042508
[TBL] [Abstract][Full Text] [Related]
15. X-linked dystonia parkinsonism: clinical phenotype, genetics and therapeutics.
Rosales RL
J Mov Disord; 2010 Oct; 3(2):32-8. PubMed ID: 24868378
[TBL] [Abstract][Full Text] [Related]
16. The natural history of sex-linked recessive dystonia parkinsonism of Panay, Philippines (XDP).
Lee LV; Maranon E; Demaisip C; Peralta O; Borres-Icasiano R; Arancillo J; Rivera C; Munoz E; Tan K; Reyes MT
Parkinsonism Relat Disord; 2002 Oct; 9(1):29-38. PubMed ID: 12217620
[TBL] [Abstract][Full Text] [Related]
17. Genome editing in induced pluripotent stem cells rescues TAF1 levels in X-linked dystonia-parkinsonism.
Rakovic A; Domingo A; Grütz K; Kulikovskaja L; Capetian P; Cowley SA; Lenz I; Brüggemann N; Rosales R; Jamora D; Rolfs A; Seibler P; Westenberger A; König I; Klein C
Mov Disord; 2018 Jul; 33(7):1108-1118. PubMed ID: 30153385
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional Alterations in X-Linked Dystonia-Parkinsonism Caused by the SVA Retrotransposon.
Pozojevic J; Algodon SM; Cruz JN; Trinh J; Brüggemann N; Laß J; Grütz K; Schaake S; Tse R; Yumiceba V; Kruse N; Schulz K; Sreenivasan VKA; Rosales RL; Jamora RDG; Diesta CCE; Matschke J; Glatzel M; Seibler P; Händler K; Rakovic A; Kirchner H; Spielmann M; Kaiser FJ; Klein C; Westenberger A
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216353
[TBL] [Abstract][Full Text] [Related]
19. A scoping review on the diagnosis and treatment of X-linked dystonia-parkinsonism.
Alonto AHD; Jamora RDG
Parkinsonism Relat Disord; 2024 Feb; 119():105949. PubMed ID: 38072720
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]